Sermorelin and sports drug testing: a prescription is not clearance
WADA’s Prohibited List names sermorelin among growth hormone-releasing hormone analogs prohibited at all times. A prescription does not automatically authorize use under anti-doping rules. Athletes should check the rules governing their sport and discuss any applicable therapeutic use exemption process with the responsible anti-doping organization before treatment.
On this page
Where sermorelin appears on the list
WADA’s 2026 Prohibited List, effective January 1, 2026, names sermorelin in section S2.2.4, which covers growth hormone releasing factors. The S2 class is prohibited at all times. This is not a rule limited to the hours immediately surrounding an event or to a particular injection technique.
The named category matters more than a seller’s description of a product as a peptide, recovery treatment or natural-hormone support. A different marketing label does not change the active substance. Check the actual prescription and every ingredient in a blend against the rules that apply to you.
This article addresses WADA-based rules. A league, federation, college program or other governing body may have its own procedures and requirements. Identify the organization responsible for your eligibility and obtain advice from that organization rather than assuming one article covers every competition.[1]
A prescription does not settle sports eligibility
USADA’s sermorelin guidance directs athletes to check the anti-doping status of medicines even when prescribed and to determine whether a therapeutic use exemption is needed. An ordinary medical intake and a sports eligibility review are different processes.
Tell the prescriber that you are subject to anti-doping rules before a treatment is selected. The clinician can explain the medical purpose and provide relevant records, but the responsible anti-doping body handles its own exemption process. A clinician’s willingness to prescribe is not the same as an exemption approval.
The same distinction applies when a service markets itself to active adults or athletes. A testimonial from a competitor does not establish that use was permitted under your rules. Ask for a clear route to the responsible authority rather than relying on the clinic’s confidence.[2]
Understand the TUE process before assuming it applies
A therapeutic use exemption is a formal process, not a note added to a prescription. USADA provides resources explaining who may need to apply and how to obtain guidance. Whether an application is appropriate, what documents are needed and when it must be submitted depend on the rules and your circumstances.
Do not assume that any diagnosis or any prescribed medicine guarantees an exemption. Ask the relevant organization to explain its requirements and work with the treating clinician to supply accurate records. Do not reshape symptoms or select a diagnosis simply to fit an application.
If treatment is medically necessary, coordination should happen with the treating professional and the responsible anti-doping organization. This guide does not tell you to delay urgent care. It also does not promise retrospective approval; obtain specific advice for your situation instead of relying on a general exception described online.[3]
Why detection-window advice is the wrong planning tool
Online discussions sometimes ask how long a product remains detectable or how close to an event it can be used. That framing does not answer whether the use itself is permitted. A substance prohibited outside competition does not become authorized because a seller predicts a negative test on a particular date.
This guide does not provide timing instructions to evade testing. A more useful question is which rules apply, whether a legitimate medical treatment requires formal approval and how to document the decision. Those questions can be resolved before paying for a plan or receiving medicine.
A short claimed half-life also does not settle the administrative or medical issues. Avoid using an online calculator, forum anecdote or generic peptide chart as a substitute for an official answer. Keep the discussion centered on eligibility and appropriate care rather than on the likelihood of being tested.
Check every ingredient and keep records
A blend may contain more than sermorelin, and each ingredient needs its own review. WADA also names several other growth hormone-releasing compounds. Switching to a differently marketed blend or an oral secretagogue therefore does not automatically resolve the anti-doping question.
Keep the actual label, ingredient information, prescriber details and any written guidance from the responsible organization. If the formulation or treatment changes, ask whether the earlier advice still applies. An answer about one named medicine should not be stretched to cover a later combination.
When contacting the organization, provide the complete product name and explain whether you already compete under its rules or are considering entering an event. Ask who handles the question if it falls outside that organization’s responsibility. An answer from the wrong body can leave the original eligibility question unresolved even when everyone is acting in good faith.
If you have already received treatment, give an accurate history when seeking advice. Do not describe a past exposure as a hypothetical future plan. The responsible organization and your clinician need the actual facts to explain the relevant process. Keep their written instructions with your records rather than relying on an informal summary passed through another person.
If a seller will not provide the ingredient list clearly, that prevents a meaningful check. Resolve the identity of the product before making a decision. A claim that ingredients are proprietary is not useful when your clinician and anti-doping organization need to know what the treatment contains.[1]
| Before treatment | What to establish |
|---|---|
| Identify your rules | Which federation, league or anti-doping organization governs your participation. |
| Identify the product | Every active ingredient and the actual dosage form. |
| Tell the clinician | That anti-doping requirements are part of the treatment decision. |
| Ask about a TUE | The applicable process, documentation and timing. |
| Keep the answer | Written guidance tied to the actual treatment. |
Evidence summarized from the linked sources in this section; this is not a head-to-head treatment trial.
Common questions from recreational and masters athletes
Do these rules matter if I am not a professional? Professional status alone does not determine which rules apply. Ask the organizer or governing body whether your event or membership subjects you to anti-doping requirements, including any masters or age-group procedures.
Can I rely on a coach saying it is fine? A coach can help you find the right contact, but an informal assurance is not a substitute for an official eligibility or exemption decision. Keep the actual response from the organization responsible for your rules.
Does a prescription from a different state change the answer? Where a prescription was issued does not, by itself, establish permission under sports rules. The medical, dispensing and competition questions remain separate. Resolve each with the responsible professional or organization before relying on a treatment plan.
Related reading
Sources and reading notes
Studies of another molecule or patient group are identified where discussed; they do not establish the same result for compounded sermorelin.
This is not medical advice
Sermorelin is a prescription drug. You cannot legally buy it in the United States without a prescription, and nothing on this page is a recommendation to take it, to take a particular amount of it, or to stop anything you have been prescribed. Talk to a clinician who knows your history, and tell them what else you take.
4 of 99 sermorelin sellers, showing different ways treatment is priced. Each review lists its source date.
Partner links can earn us a commission. How we’re funded.
Narrow this board
Showing all 4 sellers.
EmbodyPartner
$99 per month
a recurring rate
70/100 disclosure score
sermorelin injections; dose and vial size not stated
System LabsPartner
$89 first month
an introductory offer
65/100 disclosure score
page labels the supply as quarterly, 9 mg
CoreAge RxPartner
$99 per month
a starting price
45/100 disclosure score
dose not stated
Lavender Sky Health
$199 per 15 mg supply
a prepaid total
75/100 disclosure score
Red Rock Pharmacy injectable sermorelin, 15 mg; consultation extra
Sellers that pay us a commission come first in their group, identified by a Partner badge. That position is the only thing paying us buys. Below it, each group is ordered by what each seller states about its own figure: the kind of price first, then the figure itself. The price, the dose, the score and the review read the same either way. Compare the complete directory on compare sermorelin sellers. 1 of these 4 sellers names the pharmacy that compounds its sermorelin — Lavender Sky Health (Red Rock Pharmacy (15 mg injectable option)). A pharmacy named on a seller’s GLP-1 pages does not count: it says nothing about who makes this drug.